
Real-world patients. Real-world impact with the EVOQUE system.
TMTT Today issue #14 – November 2025
Download


*Performance data on file and marketing evaluation
‡Cardioband has been discontinued and it is not available for commercial use
MR, mitral regurgitation; TMTT, transcatheter mitral and tricuspid therapies; TR, tricuspid regurgitation; TEER, transcatheter edge-to-edge repair.
For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).
PP--EU-5247v9.0